Alterity Therapeutics
ATHE
23 hedge funds and large institutions have $5.54M invested in Alterity Therapeutics in 2013 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 5 closing their positions.
96% more call options, than puts
Call options by funds: $2.34M | Put options by funds: $1.19M
60% more capital invested
Capital invested by funds: $3.45M → $5.54M (+$2.08M)
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
17% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 6
10% more funds holding
Funds holding: 21 → 23 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$379K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$206K |
| 3 |
Millennium Management
New York
|
+$197K |
| 4 |
FIM
Freedom Investment Management
Hartford,
Connecticut
|
+$138K |
| 5 |
GBA
Garrison Bradford & Associates
New York
|
+$137K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$677K |
| 2 |
Renaissance Technologies
New York
|
-$671K |
| 3 |
AG
Aperio Group
Sausalito,
California
|
-$283K |
| 4 |
PA
Para Advisors
New York
|
-$206K |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$164K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PA
26
Para Advisors
New York
| – | -$206K | -833 | Closed |
|
|
27
Federated Hermes
Pittsburgh,
Pennsylvania
| – | -$164K | -667 | Closed |
|
28
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$83.8K | -280 | Closed |
|
ATHE Hedge Fund Activity: Q4 2013 in Review
23 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Alterity Therapeutics (ATHE) for Q4 2013, worth a combined $5.54M — up 60% from $3.45M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new ATHE positions and 5 closed out — a net gain of 2 holders — while 7 added to existing stakes and 6 trimmed.
The largest buyer was Jane Street, adding an estimated $379K. The largest seller was Morgan Stanley, cutting an estimated $677K.
- 23 institutional investors held Alterity Therapeutics (ATHE) as of Q4 2013, up from 21 in Q3 2013.
- Funds reported $5.54M of Alterity Therapeutics stock for Q4 2013, up 60% quarter-over-quarter.
- 7 funds opened new Alterity Therapeutics positions in Q4 2013 and 5 closed out, a net change of +2 holders.
- The largest Alterity Therapeutics buyer in Q4 2013 was Jane Street, an estimated $379K added.
- The largest Alterity Therapeutics seller in Q4 2013 was Morgan Stanley, an estimated $677K sold.
Based on aggregated 13F filings for Q4 2013.